Biomedical polymers: synthesis, properties, and applications
Biomedical polymers have been extensively developed for promising applications in a lot of
biomedical fields, such as therapeutic medicine delivery, disease detection and diagnosis …
biomedical fields, such as therapeutic medicine delivery, disease detection and diagnosis …
[HTML][HTML] Evolution of blood–brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies
L Han, C Jiang - Acta Pharmaceutica Sinica B, 2021 - Elsevier
Blood–brain barrier (BBB) strictly controls matter exchange between blood and brain, and
severely limits brain penetration of systemically administered drugs, resulting in ineffective …
severely limits brain penetration of systemically administered drugs, resulting in ineffective …
Cell-derived nanovesicle-mediated drug delivery to the brain: principles and strategies for vesicle engineering
Y Liang, Z Iqbal, J Lu, J Wang, H Zhang, X Chen… - Molecular Therapy, 2023 - cell.com
Develo** strategies toward safe and effective drug delivery into the central nervous
system (CNS) with improved targeting abilities and reduced off-target effects is crucial. CNS …
system (CNS) with improved targeting abilities and reduced off-target effects is crucial. CNS …
Cell membrane-coated mimics: a methodological approach for fabrication, characterization for therapeutic applications, and challenges for clinical translation
Cell membrane-coated (CMC) mimics are micro/nanosystems that combine an isolated cell
membrane and a template of choice to mimic the functions of a cell. The design exploits its …
membrane and a template of choice to mimic the functions of a cell. The design exploits its …
Cell membrane coating technology: a promising strategy for biomedical applications
Y Liu, J Luo, X Chen, W Liu, T Chen - Nano-Micro Letters, 2019 - Springer
Cell membrane coating technology is an approach to the biomimetic replication of cell
membrane properties, and is an active area of ongoing research readily applicable to …
membrane properties, and is an active area of ongoing research readily applicable to …
Biologically modified nanoparticles as theranostic bionanomaterials
Inspired by natural biology, cell membrane-mimetic surface engineering and cell membrane
camouflaging technology have been widely investigated. Notably, the cell membrane …
camouflaging technology have been widely investigated. Notably, the cell membrane …
[HTML][HTML] Stem cell membrane-coated abiotic nanomaterials for biomedical applications
I Ferreira-Faria, S Yousefiasl, A Macário-Soares… - Journal of controlled …, 2022 - Elsevier
Nanoscale materials have been extensively employed for diagnostic and therapeutic
purposes. However, the developed nanosystems still suffer from some limitations, namely …
purposes. However, the developed nanosystems still suffer from some limitations, namely …
Multiscale NIR-II imaging-guided brain-targeted drug delivery using Engineered Cell membrane Nanoformulation for Alzheimer's Disease Therapy
D Huang, Q Wang, Y Cao, H Yang, M Li, F Wu… - ACS …, 2023 - ACS Publications
Effective drug delivery in the central nervous system (CNS) needs to have long blood-
circulation half-lives, to pass through the blood–brain barrier (BBB), and subsequently to be …
circulation half-lives, to pass through the blood–brain barrier (BBB), and subsequently to be …
Biomimetic cell membrane‐coated poly(lactic‐co‐glycolic acid) nanoparticles for biomedical applications
Poly (lactic‐co‐glycolic acid)(PLGA) nanoparticles (NPs) are commonly used for drug
delivery because of their favored biocompatibility and suitability for sustained and controlled …
delivery because of their favored biocompatibility and suitability for sustained and controlled …
Targeted treatment of ischemic stroke by bioactive nanoparticle-derived reactive oxygen species responsive and inflammation-resolving nanotherapies
J Yuan, L Li, Q Yang, H Ran, J Wang, K Hu, W Pu… - ACS …, 2021 - ACS Publications
Stroke is a primary cause of death and disability worldwide, while effective and safe drugs
remain to be developed for its clinical treatment. Herein, we report bioactive nanoparticle …
remain to be developed for its clinical treatment. Herein, we report bioactive nanoparticle …